Maximizing hemodynamic effectiveness of biventricular assistance by direct cardiac compression studied in ex vivo and in vivo canine models of acute heart failure  by Artrip, John H. et al.
The use of synchronized biventricular epicardialcompression achieved by inflation of a pneumati-
cally driven bladder surrounding the heart has been
proposed as a means of assisting the failing heart.1,2
Unlike other types of assist devices, such compression
devices do not contact the blood and thus may be asso-
ciated with fewer complications related to throm-
boembolic events. The physiologic principles by
which direct cardiac compression (DCC) enhances
ventricular pumping strength have been demonstrated
in isolated canine hearts.3-6 The end-systolic pressure-
volume relationship (ESPVR) is shifted upward (indi-
cating increased effective contractile strength) by an
amount proportional to the inflation pressure of the
compression bladder. 
Objective: Direct cardiac compression improves effective ventricular con-
tractility. However, associated reductions in filling volumes and increases in
arterial pressure occurring at the onset of direct cardiac compression limit
the degree to which cardiac output is augmented. We tested the hypothesis
that active preload and afterload control maximizes the hemodynamic effec-
tiveness of direct cardiac compression.
Methods and results: Studies in isolated canine hearts loaded with a comput-
er-controlled volume servo system that mimicked heart failure were used to
clearly define the hemodynamic effects of direct cardiac compression.
Immediately on initiation of direct cardiac compression, ventricular end-
diastolic pressure and volume decreased substantially, arterial pressure
increased, but stroke volume did not change significantly. When end-dias-
tolic pressure was restored to about 20 mm Hg, stroke volume doubled;
decreasing afterload resistance further increased stroke volume by about
30%. Such load adjustments were then tested in vivo in a canine model of
acute heart failure induced by coronary artery microembolizations titrated to
decrease cardiac output to 33% ± 9% of control as end-diastolic pressure
rose to 20.6 ± 2.2 mm Hg. Direct cardiac compression decreased end-dias-
tolic pressure to 11.4 ± 2.6 mm Hg while increasing cardiac output from 0.8
± 0.2 to 1.4 ± 0.5 L/min (to only ~55% of normal). Restoring end-diastolic
pressure to 19.6 ± 2.2 mm Hg by infusions of saline solution increased car-
diac output to 1.9 ± 0.5 L/min. Afterload reduction (nitroprusside), while
maintaining end-diastolic pressure at 19.8 ± 1.3 mm Hg, increased cardiac
output to its baseline, 2.8 ± 1.1 L/min. 
Conclusions: Direct cardiac compression significantly improves ventricular
pumping capacity and can restore cardiac output to about 60% of normal in
the setting of acute heart failure. When combined with active preload and
afterload manipulations, direct cardiac compression can restore cardiac out-
put to normal.  (J Thorac Cardiovasc Surg 2000;120:379-86)
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In both the isolated ejecting heart and the heart in
situ, application of biventricular DCC also results in
decreased right ventricular (RV) and left ventricular
(LV) preload volumes and pressures.6 On the basis of
measurements showing that the end-diastolic pres-
sure-volume relationship (EDPVR) is minimally
altered by the device,7 it has been demonstrated that
the reduction in preload is mainly a consequence of
the increased pumping capacity of the supported
heart. Although reductions of preload are clinically
beneficial, they decrease the net flow and pressure-
generating capacity of the heart (Starling mechanism)
even in the presence of DCC.6,7 For example, in a
canine model of severe acute ischemic heart failure
(defined as a reduction in cardiac output to ~30% of
normal), DCC doubled cardiac output, but net flow
during support amounted to only about 60% of nor-
mal. This increase in cardiac output was associated
with a decrease in LV end-diastolic pressure (EDP)
from a mean value of 22 to 12 mm Hg and an increase
in arterial pressure from 55 to 100 mm Hg.7 However,
according to physiologic principles, cardiac output
can be normalized if preload and afterload are appro-
priately manipulated. 
The purpose of this study was therefore to test
whether manipulation of ventricular preload and after-
load could enhance cardiac output in hearts with severe
acute heart failure supported by DCC. An ex vivo iso-
lated canine heart preparation, which allows precise
measurement of ventricular volumes and control over
preload and afterload, was used to elucidate the physi-
ologic principles. The hemodynamic effects of DCC
were then tested in vivo in a canine model of acute
ischemic heart failure at different levels of compression
pressures and during serial manipulations of preload
and afterload. 
Methods
A total of 20 adult male mongrel dogs (12 for isolated heart
and 8 for acute in vivo studies) weighing between 22.0 and
27.6 kg (mean ± SD, 24.1 ± 1.8 kg) were used for these stud-
ies. All animals received humane care in compliance with the
“Guide for the Care and Use of Laboratory Animals” pub-
lished by the National Institutes of Health (NIH Publication
No. 85-23, revised 1985). For all studies, dogs were anes-
thetized with pentobarbital sodium (30 mg/kg, intravenous-
ly), intubated with an 8F endotracheal tube, and maintained
with mechanical ventilation using humidified room air
(Harvard Apparatus Inc, Holliston, Mass). 
DCC device. Mechanical biventricular DCC was provided
by the CardioSupport System (CSS, Cardio Technologies
Inc, Pine Brook, NJ). This device (Fig 1) consists of an inflat-
able cuff with 2 epicardial electrocardiogram sensors, a pneu-
matic pressure and vacuum generator, and a computer con-
sole. The cuff fits around the heart with an inflation bladder
that circumscribes both ventricular chambers and covers
approximately 50% of the epicardium. The cuff is held to the
heart with negative attachment pressure (~200 mm Hg)
applied to the LV apex. A solid-state MikroTip catheter
(Millar Instruments Inc, Houston, Tex) placed in the driveline
near the cuff is used to measure the pressure inside the infla-
tion bladder. A digitally controlled mechanical pneumatic
pump is used to control the amount (PDCC) and duration
(tDCC) of compression pressure. The device can generate a
PDCC over 200 mm Hg with tDCC varying between 10% and
50% of the cardiac cycle; PDCC values between 50 and 150
mm Hg and tDCC values of 40% were typically used because
prior studies have shown that these values provide optimal
hemodynamic benefit. The electrocardiogram measured
through the epicardial leads is used by the device to synchro-
nize compressions to the intrinsic QRS complex. 
Ex vivo canine heart study. Six isolated cross-perfused
canine hearts (each experiment using 2 dogs) were studied by
means of methods that were similar to those described previ-
ously.8 In brief, the femoral arteries and veins of 1 dog (“sup-
port dog”) were cannulated and connected to a perfusion sys-
tem used to supply oxygenated blood to the isolated heart.
The heart from the second dog (“heart donor dog”) was
removed while metabolically supported by arterial flow from
the support dog. Two metal adapters sutured to the mitral and
tricuspid valve rings held the isolated heart to servo-pump
systems used to measure and control the ventricular volumes
via water-filled balloons placed inside each ventricle. A
Millar pressure transducer placed inside each balloon was
used to measure intracavitary pressures. The servo systems
were controlled by a computer programmed to simulate the
hydraulic impedances of the systemic and pulmonary circuits
and allowed the ventricles to eject in series with each other in
a physiologic manner.9,10
Protocol. Heart rate was set between 100 and 140
beats/min by atrial pacing, and the values of the parameters
of the simulated vascular systems were adjusted to approxi-
mate the hemodynamics of the heart failure state: RV EDP, 5
to 15 mm Hg; LV EDP, 15 to 20 mm Hg; stroke volume,
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Fig 1.  Schematic representation of the biventricular com-
pression device (CardioSupport System [CSS], Cardio
Technologies Inc, Pine Brook, NJ). ECG, Electrocardiogram. 
about 5 mL; peak arterial pressure, 90 to 100 mm Hg. Under
these conditions, baseline ESPVR and EDPVR, as well as
stroke volume–end-diastolic volume relations (EDV-SV)
were obtained by recording pressure-volume data at 3 to 6
different preload volumes. Preload volume changes were
obtained by simulating adjustments in the total circulatory
volume of the computerized vascular system. The DCC
device was then placed on the heart, compressions were ini-
tiated, and the measurements were repeated. Finally, the
sequence was repeated after a reduction in simulated sys-
temic vascular resistance.
In vivo canine heart study. A total of 8 dogs were used to
test the effects of adjusting PDCC and ventricular load on
DCC-assisted ventricular function in vivo. For each in vivo
experiment, the right carotid artery was cannulated with a
Millar pressure transducer that was introduced into the left
ventricle for measurement of LV pressure. The left carotid
artery was cannulated with a Tygon catheter (Saint-Gobain
Performance Plastics Corporation, Akron, Ohio) connected to
a pressure transducer (Statham P32, Gould; Carolina
Medical, King, NC) for measurement of arterial pressure. A
lateral thoracotomy was performed through the fifth inter-
costal space. A flow probe (Transonic Systems Inc, Ithaca,
NY) was placed around the ascending thoracic aorta to mea-
sure cardiac output. A custom-made silicone catheter was
introduced into the left anterior descending coronary artery
that was used for coronary microembolizations to create heart
failure.11,12
Coronary microembolization. Aliquots of 90 µm glass
beads (~25,000) were injected into the coronary artery every
3 to 5 minutes until a severe but stable level of acute heart
failure was achieved (~60%-70% of the normal baseline car-
diac output). Ventricular ectopy was treated with intravenous
lidocaine (20 mg/kg loading dose followed by a constant
infusion of 1 mg · kg–1 · min–1). 
Protocol. After the induction of stable heart failure and
recording of hemodynamic data, an appropriately sized cuff
was placed on the heart, and ventricular compressions were
synchronized with the native electrocardiogram. PDCC was
increased by increments of about 50 mm Hg to obtain data at
50, 100, and 150 mm Hg. To test the effects of preload and
afterload adjustments in vivo, we used normal saline solution
to increase the EDP to about 20 mm Hg, followed by nitro-
prusside (0.3-0.9 µg · kg–1 · min–1) to lower the mean arterial
pressure to about 60 mm Hg. Volume loading was also
repeated during nitroprusside infusion since the resulting
venodilation decreased filling pressures. Data were recorded
after each intervention and only after obtaining a stable state.
Due to instability of this preparation, only 4 animals com-
pleted both the PDCC and ventricular loading portions of the
protocol; thus, an additional 2 animals had to undergo only
the ventricular loading segment of the protocol to achieve 6
successful experiments.
Data collection and statistical analysis. Data were record-
ed on an 8-channel chart recorder (Gould Instrument Systems
Inc, Valley View, Ohio) equipped with an analog-to-digital
converter; periods of interest were digitally sampled (1000
Hz) and analyzed off-line.
For the isolated heart study, the end-systolic pressure (ESP)
and volume (ESV) of each beat were determined by identify-
ing the upper left hand corner of each pressure-volume loop
and end-diastolic pressure (EDP) and volume (EDV) points
were determined by identifying the bottom right hand corner.
The ESPVRs and EDV-SV curves were characterized by lin-
ear regression analysis, whereas nonlinear regression was
used for EDPVRs.
Statistical comparisons of the linear curves between con-
trol and test conditions were accomplished by repeated-mea-
sures analysis of covariance (RM-ANCOVA). Nonlinear
EDPVRs were linearized (logarithmic transformation) before
application of RM-ANCOVA.6,7 Hemodynamic parameters
were expressed as mean ± SD and were compared between
various conditions by means of repeated-measures analysis
of variance (RM-ANOVA) with indicator variables used to
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Table I.  The effect of increasing preload (↑P) and reducing afterload (↓A) on DCC-assisted ventricular function
in isolated canine hearts under conditions of simulated heart failure
HF HF+DCC DCC+↑P DCC+↑P +↓A
Left ventricle
ESP (mm Hg) 91.7 ± 6.1 87.1 ± 20.3 115.6 ± 13.9*† 72.4 ± 3.3*†
EDP (mm Hg) 17.6 ± 4.1 8.0 ± 2.2*† 19.2 ± 7.8† 20.2 ± 6.3
ESV (mL) 33.6 ± 10.2 15.9 ± 6.4*† 24.8 ± 9.2*† 12.9 ± 3.2*†
EDV (mL) 38.7 ± 10.2 21.3 ± 6.6*† 34.3 ± 6.7† 24.9 ± 5.9*†
SV (mL) 5.1 ± 1.9 5.7 ± 1.7 10.3 ± 3.1*† 12.7 ± 4.4*
Right ventricle
ESP (mm Hg) 37.9 ± 10.9 69.0 ± 8.1*† 67.7 ± 8.7* 66.3 ± 9.7*
EDP (mm Hg) 12.8 ± 4.6 8.9 ± 5.7 12.7 ± 4.5 11.7 ± 5.7
ESV (mL) 22.2 ± 8.4 9.2 ± 2.6*† 8.3 ± 6.3* 1.3 ± 0.9*†
EDV (mL) 27.4 ± 9.0 15.1 ± 4.4*† 18.9 ± 8.9 13.5 ± 7.8*
HF, Heart failure; ESP, end-systolic pressure; EDP, end-diastolic pressure; ESV, end-systolic volume; EDV, end-diastolic volume; SV, stroke volume. All values are
mean ± SD. 
*P < .05 vs HF.
†P < .05 compared with the value in column to the left based on repeated measures of variance with indicator variables.
test the effects of specific hemodynamic interventions.13
Bonferroni corrections were used for post hoc tests to control
for the effects of multiple contrasts. All statistical analyses
were performed with commercially available software (SAS
version 6.12, SAS Institute, Inc, Cary, NC).
Results
Effect of load adjustment on DCC-assisted hemo-
dynamics in isolated hearts. Parameter values of the
simulated vascular system were adjusted to mimic the
hemodynamic conditions of heart failure as shown in
Table I. Upon initiating DCC with a cuff pressure of
about 100 mm Hg (HF+DCC), RV and LV EDPs and
EDVs decreased but stroke volume was not substantial-
ly affected. Volume loading was then simulated by
increasing the simulated total intravascular volume so
that RV and LV EDPs were increased to higher values
(DCC+↑P). This resulted in increases in ESPs, and
stroke volume almost doubled from its baseline value.
Systemic afterload resistance was then decreased
(DCC+↑P+↓A), which resulted in a decrease in LV
ESP and a reduction in LV EDV with a further increase
in stroke volume. These results show that initiation of
DCC decreases preload volume and pressure and that
hemodynamic effectiveness of DCC can be enhanced
by manipulating preload and afterload.
To further clarify the mechanisms of DCC, we generat-
ed ESPVRs and EDPVRs from data obtained from these
isolated hearts over a range of preload volumes. DCC
shifted the ESP-ESV points toward lower ESVs and
higher ESPs (Fig 2, data from a representative heart). On
average, the slope of the ESPVR increased from 3.32 to
3.96 mm Hg/mL (P = .006, RM-ANCOVA) and the vol-
ume axis-intercept dropped from 1.9 to –6.9 mL (P =
.03), both changes indicating an increase in effective ven-
tricular contractility. DCC did not have a statistically sig-
nificant effect on the EDPVR (P values from RM-
ANCOVA for differences in slopes and elevations of the
linearized EDPVRs were .55 and .74, respectively). 
Data pertaining to the EDV-SV relation of these
hearts at 2 levels of afterload resistance are shown in
Fig 3 (representative example). At normal afterload, the
average slope of EDV-SV relationship was unchanged
by DCC (0.22 at baseline vs 0.20 during DCC, P = .71
by RM-ANCOVA); the y-axis intercept increased from
–2.5 to 0.8 mL with DCC (P = .06). With decreased
afterload resistance, the slope increased from 0.3 to 0.4
(P = .01); although the mean y-axis intercept increased
from –2.0 to 0.6 mL, RM-ANCOVA did not reveal a
statistically significant difference in mean elevation
between these curves. RM-ANCOVA also revealed that
although there was no significant difference between
the baseline EDV-SV relations at the 2 different after-
loads, there was a statistically significant difference in
slopes during DCC between the 2 afterloading condi-
tions (P = .001).
Thus, for both levels of afterload, DCC shifted the
EDV-SV relationship upward, indicating that at a given
preload flow-generating capacity is increased signifi-
cantly by DCC. These results reveal the physiologic
mechanisms by which the effectiveness of the DCC can
be maximized.
Effect of PDCC. DCC was next tested in the setting of
acute ischemic heart failure in vivo (n = 6) at PDCC val-
ues of 50, 100, and 150 mm Hg (Table II). Coronary
embolization acutely decreased cardiac output, mean
arterial pressure fell to 61.8 ± 5.6 mm Hg, and EDP
increased to 19.8 ± 5.5 mm Hg. DCC-assisted cardiac
output, stroke volume, mean arterial pressure, and LV
systolic pressure increased progressively with increases
in PDCC, although only the changes in mean arterial pres-
sure were statistically significant. In contrast, EDP incre-
mentally decreased to 12.5 ± 4.0 mm Hg. At the highest
level of PDCC, cardiac output was increased by about
50% compared with the unassisted heart failure state, but
this still amounted to only about 50% of normal. Thus,
as observed in the isolated hearts, the ability of DCC to
increase cardiac output in vivo is hindered by decreases
in filling pressure. For all parameters, there was only a
marginal hemodynamic impact of increasing PDCC from
100 to 150 mm Hg. For this reason, further studies are
performed at PDCC of 100 mm Hg. 
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Fig 2. Effect of DCC on the LV ESPVR and EDPVR from a
representative isolated canine heart. The ESPVR is shifted
upward in response to DCC, whereas there is no statistically
significant effect on the EDPVR. See text for details. 
Effect of volume loading and afterload reduction.
To test whether cardiac output during DCC could be
augmented through adjustments of ventricular load, we
performed experiments in 6 animals in which normal
saline solution and nitroprusside were infused. The
results (Fig 4) show that as in the previous group of
animals, embolization substantially decreased cardiac
output, mean arterial pressure, LV systolic pressure,
and stroke volume, whereas LV EDP and systemic vas-
cular resistance increased compared with normal.
Initiation of DCC at 132 ± 24 mm Hg induced a
decrease in EDP of about 8 mm Hg (from 20.6 ± 2.2
mm Hg to 11.4 ± 2.6 mm Hg, P = .001), and cardiac
output increased from 0.8 ± 0.2 to 1.4 ± 0.5 L/min (P =
.03), attaining a value of about 50% of normal (+DCC).
When EDP was restored to 19.6 ± 2.2 mm Hg by saline
infusion, cardiac output increased to 1.9 ± 0.5 L/min
(+↑P, P = .04). Cardiac output was further increased to
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Fig 3. Effect of DCC on the relationship between end-diastolic volume and stroke volume at normal (A) and low
(B) afterload arterial resistances from a representative heart. DCC shifts the end-diastolic volume–stroke volume
relationship upward. See text for details. 
A B
Table II. The effect of compression pressure on hemodynamic parameters in ischemic heart failure
DCC-assisted
Baseline HF PDCC = 50 mm Hg PDCC = 100 mm Hg PDCC = 150 mm Hg 
(n = 6) (n = 6) (n = 5) (n = 6) (n = 6)
Measured PDCC (mm Hg) — — 55.4 ± 12.0 99.2 ± 7.3 146.7 ± 3.8
Average CO (L/min) 2.65 ± 0.95 0.75 ± 0.34*† 0.93 ± 0.39* 1.11 ± 0.40* 1.18 ± 0.55*
Percent of baseline CO — 28 ± 10* 35 ± 14* 43 ± 16* 46 ± 22*
Heart rate (beats/min) 141.3 ± 17.0 117.2 ± 6.6*† 118.2 ± 7.7* 117.3 ± 7.3* 118.7 ± 5.0*
MAP (mm Hg) 102.0 ± 19.6 63.8 ± 11.7*† 78.0 ± 14.2*† 88.7 ± 13.8 93.2 ± 14.6†
SVR (mm Hg · L · min) 2.44 ± 0.58 5.91 ± 2.28† 6.35 ± 4.49* 5.71 ± 3.66 6.49 ± 5.42*
LV systolic pressure (mm Hg) 121.3 ± 12.9 72.3 ± 14.6*† 95.0 ± 18.5 117.7 ± 17.3† 121.3 ± 20.0†
LV EDP (mm Hg) 8.2 ± 4.7 19.8 ± 5.5*† 18.2 ± 5.3* 14.8 ± 6.3* 12.5 ± 4.0†
SV (mL)† 18.6 ± 5.1 6.5 ± 3.2*† 8.0 ± 3.8* 9.6 ± 3.9* 10.1 ± 4.9*
PDcc, Cardiac compression pressure; HF, heart failure; CO, cardiac output; MAP, mean arterial pressure; SVR, systemic vascular resistance; EDP, end-diastolic pres-
sure; SV, stroke volume. All values are mean ± SD. 
*P < .05 versus baseline. 
†P < .05 compared with value in column to the left from analysis based on RM-ANOVA with indicator variables.
a value of 2.5 ± 0.9 L/min (98% of normal) following
the afterload reduction by nitroprusside (+↓A, P =
.002). However, the vasodilatory effect of nitroprusside
was not restricted to arterial resistance but also caused
venodilation, as evidenced by a (statistically not signif-
icant) drop in LV EDP from 19.6 ± 2.2 to 12.8 ± 3.0
mm Hg (P = .38). LV EDP was again increased by
another infusion of normal saline solution to a value of
19.8 ± 1.3 mm Hg, at which point cardiac output
increased to 2.8 ± 1.1 L/min, or 105% of normal
(+↓A+↑P). Thus, active manipulation of preload and
afterload provides an effective means of modulating
the hemodynamic impact of DCC in vivo.
Discussion
Direct epicardial compression in synchrony with
native ventricular contraction can increase effective
contractility and overall pressure and flow-generating
capacity of the heart (Figs 2 and 3). One effect of the
acutely boosted ventricular pumping capacity is that
filling pressures and volumes are decreased substan-
tially on initiation of assistance, a factor that limits the
immediate augmentation of cardiac output and systolic
pressure. These observations are consistent with those
of previous studies done in the setting of acute heart
failure showing that, on average, cardiac output
reached about 60% of normal during DCC.7 Cardiac
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Fig 4. Summary of the effect of increasing preload (↑P) and reducing afterload (↓A) on DCC-assisted ventricular
function. The cardiac output (CO), mean arterial pressure (MAP), systemic vascular resistance (SVR), LV end-sys-
tolic pressure (LV ESP), LV end-diastolic pressure (LV EDP), and stroke volume (SV) are illustrated after each inter-
vention. The heart rate varied slightly between the treatment conditions with respective values of (from left to right)
137.8 ± 14.2, 118.0 ± 7.3, 114.8 ± 5.8, 110.4 ± 9.0, 109.6 ± 10.1, 107.0 ± 9.6 beats/min. *P < .05 versus baseline; P
values over each bar show the results of RM-ANOVA with indicator variables to parameterize specific contrasts. 
output and pressure augmentations are readily
enhanced, however, by active adjustment of filling
pressure through administration of intravenous fluids.
Additional increases in cardiac output can be attained
by counteracting arterial vasoconstriction normally
encountered in heart failure, provided there is adequate
blood pressure reserve during these interventions. In
the present study, for hearts pumping only about 30%
of normal cardiac output, DCC in combination with
such preload and afterload manipulations could restore
cardiac output to normal.
The interactions between the left ventricle, a DCC
device, and the vascular load can be explained with the
use of graphic representations of theories of ventricular
vascular coupling14 (Fig 5). ESPVRs (dot-dashed lines),
pressure-volume loops (solid lines), and effective arteri-
al elastance lines (E
a
; dotted lines, an index of arterial
afterload resistance) are shown in this figure. The base-
line ESPVR during heart failure, accompanying pres-
sure-volume loop, and baseline arterial elastance line are
all shown in black. The influence of DCC is to shift the
ESPVR upward in an approximately parallel manner
(blue dot-dashed line) by an amount proportional to
PDCC.6,7 When DCC is applied, preload is reduced, and
the resulting pressure-volume loop, assuming no change
in arterial properties, is shown by the solid blue loop.
Stroke volume and mean arterial pressure (the width and
height, respectively, of the pressure-volume loop) are
only marginally increased over baseline. When preload
is restored (pink pressure-volume loop), there are
marked increases in both stroke volume and ESP. With
reduction of arterial resistance (red dotted arterial elas-
tance line), stroke volume is increased further at the
expense of a slight reduction in ESP (red pressure-vol-
ume loop). Therefore, the resultant ventricular stroke
volume and ESP are critically dependent on the interac-
tions between the transmitted device compression pres-
sure (αPDCC), preload (EDP), afterload (Ea), and the
underlying ventricular function (E
es
).
For DCC devices to be used effectively in the setting
of clinical heart failure, treatment algorithms will need
to consider the underlying hemodynamic status of the
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Fig 5. Current theories of ventricular-vascular coupling can be used to relate ventricular properties with those of
the peripheral vascular system during DCC. Ventricular contractile state is quantified by the linear ESPVR where
ventricular elastance (E
es
) is the slope of the line and the unstressed ventricular volume (V
o
) is the volume axis-
intercept (solid lines). Afterload is quantified by the arterial elastance (E
a
) line where negative values for arterial
elastance (–E
a
) is the slope of the line and the EDV is the volume-axis intercept (dotted lines). Arterial elastance
(E
a
) is proportional to total peripheral resistance (TPR) and inversely proportional to the cardiac cycle duration (T):
E
a
∝TPR/T. The intersection between the E
a
line and the ESPVR provides an estimate of the end-systolic pressure-
volume point for the specified ventricular elastance (E
es
), ventricular volume (V
o
), end-diastolic volume (EDV),
and arterial elastance (E
a
). Baseline heart failure conditions are shown in black; effects of DCC are in blue; active
pre-loading during DCC is shown in pink; reduced afterload during DCC with volume loading is shown in red.
Further details are provided in the text.
patient and recognize the interrelations between PDCC,
preload, and afterload. Implementation of strategies to
maximize hemodynamic effectiveness of DCC requires
nothing more than hemodynamic monitoring and thera-
peutic interventions routinely used in the care of critical-
ly ill patients with heart failure. Peripheral arterial blood
pressure monitoring and right heart catheterization (for
assessing cardiac output and left and right heart filling
pressures) provide all necessary information for guiding
therapy. Fluid administration (such as normal saline or
colloidal solutions) and diuretics provide the means for
adjusting preload. Short-acting arterial dilators such as
nitroprusside or some calcium channel blockers could be
used for adjusting afterload resistance. 
There are clear limits to the degree to which volume
loading and afterload reduction can be used.
Pulmonary capillary pressures need to be below the
critical value necessary for normal gas exchange (typi-
cally ≤20 mm Hg) and arterial pressure needs to be
high enough to maintain organ perfusion. Additionally,
effectiveness of the device may vary depending on the
degree of baseline ventricular dilation.4 Experiments
performed thus far have used structurally normal hearts
in which acute heart failure has been induced.
However, it is predicted that the device will be signifi-
cantly more effective in the setting of long-standing
heart failure in which a significant amount of remodel-
ing and dilation have occurred. Accordingly, much less
load manipulation may be necessary in these patients.
Thus, full understanding of the interactions between
heart, device, and vascular load will ensure optimal use
of the device in the clinical setting.
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